Dental and periodontal phenotype in sclerostin knockout mice
Open Access
- 4 April 2014
- journal article
- research article
- Published by Springer Nature in International Journal of Oral Science
- Vol. 6 (2) , 70-76
Abstract
Sclerostin is a Wnt signalling antagonist that controls bone metabolism. Sclerostin is expressed by osteocytes and cementocytes; however, its role in the formation of dental structures remains unclear. Here, we analysed the mandibles of sclerostin knockout mice to determine the influence of sclerostin on dental structures and dimensions using histomorphometry and micro-computed tomography (μCT) imaging. μCT and histomorphometric analyses were performed on the first lower molar and its surrounding structures in mice lacking a functional sclerostin gene and in wild-type controls. μCT on six animals in each group revealed that the dimension of the basal bone as well as the coronal and apical part of alveolar part increased in the sclerostin knockout mice. No significant differences were observed for the tooth and pulp chamber volume. Descriptive histomorphometric analyses of four wild-type and three sclerostin knockout mice demonstrated an increased width of the cementum and a concomitant moderate decrease in the periodontal space width. Taken together, these results suggest that the lack of sclerostin mainly alters the bone and cementum phenotypes rather than producing abnormalities in tooth structures such as dentin.Keywords
This publication has 37 references indexed in Scilit:
- WNT signaling in bone homeostasis and disease: from human mutations to treatmentsNature Medicine, 2013
- Immunohistochemical evidence for sclerostin during cementogenesis in miceAnnals of Anatomy - Anatomischer Anzeiger, 2012
- Localization ofSOST/sclerostin in cementocytesin vivoand in mineralizing periodontal ligament cellsin vitroJournal of Periodontal Research, 2010
- Sclerostin in Mineralized Matrices and van Buchem DiseaseJournal of Dental Research, 2009
- Bone Mineral Density in Sclerosteosis; Affected Individuals and Gene CarriersThe Journal of Clinical Endocrinology & Metabolism, 2005
- Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt SignalingJournal of Biological Chemistry, 2005
- Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP AntagonistJournal of Experimental Medicine, 2004
- Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem diseaseJournal of Medical Genetics, 2002
- Dental and oral manifestations of SclerosteosisInternational Dental Journal, 2001
- Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing ProteinThe American Journal of Human Genetics, 2001